Antonio Pezzutto

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 726 citations · Full text

Medicine, Hematology, Oncology +12

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

Rüdiger Hehlmann, Michael Lauseker, Susanne Saußele et al. · Leukemia · 2017 · 339 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma

M Körbling, B Dörken, AD Ho et al. · Blood · 1986 · 302 citations · Full text

Medicine, Hematology, Oncology +16

Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma

M Körbling, Bernd Dörken, AD Ho et al. · Blood · 1986 · 291 citations · Full text

Medicine, Hematology, Oncology +16

Characterization of Human Inducible Costimulator Ligand Expression and Function

Alexandra Aicher, Martha Hayden-Ledbetter, William Brady et al. · The Journal of Immunology · 2000 · 242 citations · Full text

Life Sciences, Cell Biology, Immunology +17